Achromobacter xylosoxidans, a bacterial species named in 1971, is often isolated from aqueous environments, but little has been reported about its pathogenicity in humans, its epidemiological pattern, and its susceptibility to antibiotics and antiseptics. We were faced with an epidemic caused by this microorganism for 18 months in an intensive care unit. Two patients had fatal infections and 37 others were colonized. The source was the deionized water of the hemodialysis system. The 46 isolates were identified by comparison with the reference strain A. xylosoxidans ATCC 27061. The characteristic cellular fatty acids of this species were demonstrated by gas-liquid chromatography. The minimal inhibitory concentrations of 27 antibiotics were determined. The isolates were susceptible to only two: moxalactam at 4 ,ug/ml and ceftazidime at 8 Fig/ml . The minimal bactericidal concentrations of one disinfectant and three antiseptics were: sodium hypochloride, 109 p.g/ml; chlorhexidine digluconate in ethanol solution, 15 to 125 p.g/ml; polyvinylpyrrolidone iodine, 750 p.g/ml; and iodine ethanol, 312 to 625 1ig/ml.
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Achromobacter xylosoxidans was described and named by Yabuuchi et al. in 1971 (26) . Although the recognition of this species is not accepted by all taxonomists (11, 12, 14, 27) , Gilardi (10) and Tatum et al. (23) consider it distinct from other nonfermentative gram-negative rods. A. xylosoxidans is often encountered in aqueous environments. Little has been reported about its pathogenicity in humans. A Source detection studies. We performed bacteriological cultures of the following samples. Soaps and antiseptic solutions: chlorhexidine digluconate (4%), polyvinylpyrrolidone iodine (9.6%), Dakin solution; and samples from wash basins, plumbing traps, water deionization equipment, humidifiers and respirators, surfaces, wash basins, and faucets.
Fluids were filtered through 0.45-ixm membranes (Millipore Corp., Bedford, Mass.), cultivated on sheep blood agar (Biomerieux, Lyon, France). For the antiseptics, the membranes were rinsed three times with distilled water and cultivated on tryptic soy agar with 1% Tween 80 (Biomerieux); a membrane filtration method (3) was used to neutralize the antiseptics and disinfectants.
The swabs were plated on 5% sheep blood agar and brain heart broth (Biomerieux). The incubation period was 8 days at 370C.
Bacteriological studies. The following bacteria were studied: A. xylosoxidans reference strain ATCC 27061, 39 clinical isolates (2 infecting, 37 colonizing), and 2 environmental isolates.
The biochemical identifications were performed by the method of Gilardi (10) 
The number of strains giving an atypical result is shown in parentheses.
as described by Forbes (9 (17) .
The minimal bactericidal concentrations (MBCs) of antiseptics and disinfectants were established by the micromethod previously described by Surgot et al. (22) . The products studied were chlorhexidine digluconate in 0.2% ethanol, 9.6%c polyvinylpyrrolidone iodine, 1% iodine ethanol, and 10.9% sodium hypochlorite.
RESULTS
Identification of the strains. The bacteria were gramnegative rods that produced oxidase and catalase. They were motile, with peritrichous flagella. The biochemical characteristics of the strains isolated from patients and the two environmental strains are reported in Table 1 . These characteristics correlated well with those of the reference strain studied under the same conditions and also with the criteria described by Gilardi (10).
Gas-liquid chromatography of the reference strain and the 16 F.g/ml), ceftazidime, colistin (modal MIC, 8 ptg/ ml), and moxalactam (modal MIC, 4 jig/ml). The MICs of other antibiotics were all greater than 128 Ftg/ml. Some strains, including the two from the deceased patients and the environmental strains, produced r-lactamase ( Table 2) .
The MIC study allowed the strains to be separated into two groups by resistance to P-lactams, excluding moxalactam and ceftazidime ( Table 2 ). The more resistant group included the isolates from the two deceased patients and one environmental isolate (no. 2).
The results obtained with antiseptics and disinfectants are shown in Table 3 . The reference strain and our isolates all had the same susceptibility to these agents.
The epidemiological investigation found no A. xylosoxidans isolates in antiseptics or soaps, on solid surfaces, or in water obtained from different sources. The bacterium was discovered in deionized water from the faucets of the hemodialysis system in 2 of 14 rooms, but not in the deionization resins (Lewatit Resins, Bayer, Cologne, Federal Republic of Germany). To disinfect the deionized water system, we filled it with sodium hypochlorite solution (10.9%) for 15 min and then rinsed it with running water. Immediately after disinfection, A. xylosoxidans was not found in the deionized water. The chlorination process was repeated every 2 months. Since this procedure was initiated, no A. xyloxosidans infections have occurred.
DISCUSSION
Several publications (1, 4, 6, 8, 13-15, 18-21, 24, 26) reported the isolation of A. xylosoxidans from humans (Table 4 ). Only one epidemic was reported, by Foley et al.
(8).
This bacterium causes disease more readily in persons with compromised host defenses, including immunosuppressed patients with underlying disease (2, 6, 13, 14, 20) and premature babies (8, 15, 21) . Generalized infection is usually severe and very often lethal (13) (14) (15) 21) . The distribution of A. xylosoxidans in nature is not well known; an aqueous environment seems to be preferred (2, 16, 18, 23) . This species has been found by Holmes et al. (13) in a swimming pool, by Siegman et al. (14) in dialysis fluids, by Moffet and Williams (16) (13) in chlorhexidine solutions, and by several groups (8, 15, 16, 21) in incubators. (16) Spinal fluid (3) Skin, burns, ulcers (7) Throat, sputum, respiratory tract (6) Peritoneal fluid (5) Brain (1) Pus (2) Stool (2) Urine (1) Undetermined (12) 11 Blood or blood cultures (4) Urine (1) Sputum (1) Orbit swab (1) Wound swab (2) Chlorhexidine (1) Swimming pool (1) 6 Cerebral ventriculitis 1 Bacteremic pneumonia 9 Otitis (5) Surgical wound (2) Tracheal aspirate (1) Herpes zoster vesicle (1) 23 Unknown (3) Blood (4) Wounds (4) , abscess (1) Urine (7) Throat ( (20) and Holmes et al. (13) .
